[1]
Yemineni Gopi, “A RETROSPECTIVE ANALYSIS OF CARDIOTOXICITY WITH DOXORUBICIN AND TRASTUZUMAB IN BREAST CANCER HER-2 POSITIVE PATIENTS”, The Bioscan, vol. 20, no. 1, pp. 687–695, Mar. 2025.